APrf Sunita De Sousa
Grant-Funded Researcher D
School of Medicine
College of Health
Eligible to supervise Masters and PhD as Principal Supervisor - email supervisor to discuss availability.
Associate Professor Sunita De Sousa is Head of Pituitary and a Staff Specialist in Endocrinology and Clinical Genetics at the Royal Adelaide Hospital, and an Academic at Adelaide University. She was awarded the University of Adelaide Doctoral Research Medal for her PhD on prolactinomas in 2020 and now leads the South Australian Pituitary Research Group with an interdisciplinary program including higher degree research students and postdoctoral researchers, and comprising genetic, radiological, surgical, medical therapy and radiotherapy projects. Her work has provided new insights into the clinical management of pituitary adenomas and associations between pituitary adenomas and various genes including PAM, CHEK2, SDHx and GPR101/VGLL1. A/Prof De Sousa chaired the 2026 International Pituitary Society Genetic Testing Guidelines published in Nature Reviews Endocrinology and the 2025 ANZ Monogenic Diabetes Genetic Testing Guidelines published in the Medical Journal of Australia. She serves as Chair of the EndoGen National Endocrine Genetics Network and recent Board Member and Secretary of the Endocrine Society of Australia. She has authored over 70 publications (h-index 19) and received over $4M in combined grant and stipend funding including from the MRFF and NHMRC.
A/Prof De Sousa has two research streams: endocrine genetics and pituitary endocrinology. At the juncture of these subspecialties, she is highly active in the area of pituitary tumour genetics with ongoing basic and clinical international collaborations exploring putative new pituitary tumorigenesis genes including the CHEK2 gene. In endocrine genetics, her research also focuses on monogenic diabetes, hereditary pancreatitis and multiple endocrine neoplasia. Other topics in her pituitary endocrinology research include novel methodologies in both the assessment and treatment of pituitary tumours.
| Date | Position | Institution name |
|---|---|---|
| 2026 - ongoing | Head | Pituitary Service, Royal Adelaide Hospital |
| 2025 - ongoing | Deputy Head | Endocrine & Metabolic Unit, Royal Adelaide Hospital |
| 2021 - ongoing | Associate Professor | Adelaide University |
| 2019 - ongoing | Staff Specialist | Endocrine & Metabolic Unit, Royal Adelaide Hospital |
| 2018 - ongoing | Staff Specialist | South Australian Adult Genetics Unit, Royal Adelaide Hospital |
| Date | Type | Title | Institution Name | Country | Amount |
|---|---|---|---|---|---|
| 2024 | Award | ESA Early Career Plenary Award | Endocrine Society of Australia | Australia | - |
| 2024 | Award | ESA Young Investigator Award | Endocrine Society of Australia | Australia | - |
| 2022 | Award | ESA Postdoctoral Award | Endocrine Society of Australia | Australia | - |
| 2022 | Fellowship | RACP Fellows Research Establishment Fellowship | Royal Australasian College of Physiciansa | Australia | - |
| 2022 | Fellowship | Mary Overton Early Career Fellowship | Royal Adelaide Hospital | Australia | - |
| 2020 | Award | University Doctoral Research Medal | University of Adelaide | Australia | - |
| 2020 | Award | Simpson Prize for Cancer Research | Royal Adelaide Hospital | Australia | - |
| 2019 | Award | WE/ESA Australian Women in Endocrinology Travel Award | Endocrine Society of Australia / US Endocrine Society | Australia | - |
| 2019 | Award | ESA-Ipsen International Travel Award | Endocrine Society of Australia | Australia | - |
| 2019 | Fellowship | Barry Young Research Establishment Fellowship | Royal Australasian College of Physicians | Australia | - |
| 2018 | Award | Nimmo Prize | Royal Adelaide Hospital | Australia | - |
| 2018 | Award | Simpson Prize for Cancer Research | Royal Adelaide Hospital | Australia | - |
| 2017 | Scholarship | A. R. Clarkson Scholarship | Royal Adelaide Hospital | Australia | - |
| 2016 | Scholarship | NHMRC Postgraduate Scholarship | National Health and Medical Research Council | Australia | - |
| 2015 | Award | ESA Clinical Weekend Award | Endocrine Society of Australia | Australia | - |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2020 | University of Adelaide | Australia | PhD |
| 2016 | Royal Australasian College of Physicians | Australia | FRACP |
| 2015 | University of London | United Kingdom | MSc |
| 2009 | University of New South Wales | Australia | MBBS (Hons) |
| Year | Citation |
|---|---|
| 2026 | Kusay, Y., Wu, D., De Sousa, S. M. C., Drogemuller, C. J., Coates, P. T., Kok, C. H., & Scott, H. S. (2026). Evaluating NGS variant callers in a challenging genomic context with a focus on the PRSS1-PRSS2 locus for hereditary pancreatitis. Gut, 75(9), 1870-1872. |
| 2026 | Kumar, S., Duncan, E. L., Hayes, L., Berman, Y., Clifton-Bligh, R. J., & De Sousa, S. M. C. (2026). Heritable metabolic bone disorders: a guide to current genetic testing and clinical management for adult endocrinologists. Pathology, 58(2), S0031-3025(25)00350-2. Scopus1 WoS2 Europe PMC1 |
| 2026 | Ovenden, C., Tan, V., Torpy, D. J., Chapman, I., Saran, F., Jukes, A., . . . De Sousa, S. M. C. (2026). Surgical Outcomes in Knosp Grade 3 or 4 Macroprolactinomas: What Role Does Debulking Surgery Play?. World Neurosurgery, 207, 10 pages. |
| 2026 | Chowdhury, A., Marri, S., Anastasi, L., Ashenden, A., Rozek, T., Feng, J., . . . Kassahn, K. S. (2026). Semi-automated genomic newborn screening highlights complexities in reporting. npj Genomic Medicine, 11(1), 13-1-13-32. Scopus2 WoS2 Europe PMC2 |
| 2026 | Ovenden, C. D., Candy, N., Bacchi, S., Sorvina, A., Castle-Kirszbaum, M., Poonnoose, S., . . . De Sousa, S. (2026). Systematic review of the molecular basis for cavernous sinus invasion in somatotropinomas. Endocrine Related Cancer, 33(5), 17 pages. |
| 2026 | De Sousa, S. M. C., & Daly, A. F. (2026). Genetics of Familial Acromegaly and Pituitary Gigantism.. J Clin Endocrinol Metab, 111(1), S13-S26. Scopus1 WoS1 |
| 2026 | Spuler, K., White, R., Lim, W. T., Deeb, J., McNeil, J., Bouras, G., . . . De Sousa, S. M. C. (2026). A Retrospective cohort study of Knosp grade reporting of cavernous sinus invasion in pituitary macroadenomas.. Pituitary, 29(3), 7 pages. |
| 2026 | Maggacis, R. A., Sorvina, A., Hayes, L. J., Inder, W. J., Brooks, E. K., & De Sousa, S. M. C. (2026). A Contemporary Overview of Multiple Endocrine Neoplasia Syndromes: MEN Syndromes 1-5 and Beyond. Endocrine Oncology, 6(1), 14 pages. |
| 2026 | Mignone, E., Sorvina, A., Torpy, D. J., Scott, H. S., & De Sousa, S. M. C. (2026). The germline landscape of pituitary adenomas: established and emerging predisposition genes.. J Clin Endocrinol Metab, 111(8), e1926-e1936. Scopus1 WoS1 |
| 2026 | Wu, D., Radisic, G., De Sousa, S. M. C., Drogemuller, C. J., & Coates, P. T. (2026). The Epidemiology of PRSS1 Hereditary Pancreatitis and its Clinical Implications: A Systematic Review. Pancreas, 55(8), e868-e878. |
| 2026 | Wootton, E., De Sousa, S. M. C., Prince, R. L., McLeod, D. S. A., Pattison, D. A., & Grossmann, M. (2026). Primary Hyperparathyroidism in Adults: Recent Developments in Diagnosis and Management. Medical Journal of Australia, 224(5), e70194-1-e70194-11. |
| 2026 | Bindra, J. K., Maggacis, R., Hayes, L., Field, M., Vakulin, C., Ephraums, L., . . . Clifton-Bligh, R. J. (2026). An integrated approach to reclassify MEN1 variants of uncertain significance using clinical and computational evidence. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 15 pages. |
| 2026 | Mignone, E., Saran, F., Psaltis, A., Jukes, A., Paul, R., Carroll, R. W., . . . De Sousa, S. M. C. (2026). Clinician decision-making in non-functioning pituitary adenomas: an Australian and New Zealand interdisciplinary survey study. Pituitary, 29(4), 11 pages. |
| 2026 | Mignone, E., Ephraums, L., Chapman, I., Quick, E., De Sousa, S. M. C., & Ho, J. (2026). Corticotroph Tumour Progression 37 Years After Bilateral Adrenalectomy with Temozolomide-Naive Response to Pembrolizumab.. Endocrine oncology (Bristol, England), EO-26-0064. |
| 2026 | De Sousa, S. M. C., Andoniadou, C. L., Daly, A. F., Gadelha, M., Gatto, F., Kamenický, P., . . . Melmed, S. (2026). Genetic testing in pituitary adenomas: a Pituitary Society International Consensus Statement. Nature Reviews Endocrinology, 15 pages. |
| 2025 | Willemsen, A. L., Torpy, D. J., De Sousa, S., Falhammar, H., & Rushworth, R. L. (2025). 17α-hydroxylase/17,20-lyase deficiency (17-OHD): A Meta-analysis of Reported Cases.. The Journal of clinical endocrinology and metabolism, 110(4), e1261-e1271. Scopus8 WoS5 Europe PMC6 |
| 2025 | De Sousa, S. M. C., Phan, J. M. N., Wells, A., Wu, K. H. C., & Scott, H. S. (2025). Improving detection of monogenic diabetes through reanalysis of <i>GCK</i> variants of uncertain significance. ACTA DIABETOLOGICA, online(8), 7 pages. Scopus3 WoS6 Europe PMC3 |
| 2025 | Candy, N. G., Mignone, E., Quick, E., Koszyca, B., Brown, A., Chapman, I. M., . . . De Sousa, S. M. C. (2025). The role of BRAF testing of Rathke's cleft cysts to identify missed papillary craniopharyngioma.. Pituitary, 28(1), 30. Scopus6 WoS5 Europe PMC3 |
| 2025 | De Sousa, S. M. C., Phan, J. M. N., Wells, A., Wu, K. H. C., & Scott, H. S. (2025). Correction to: Improving detection of monogenic diabetes through reanalysis of GCK variants of uncertain significance (Acta Diabetologica, (2025), 10.1007/s00592-025-02449-8). Acta Diabetologica, 62(10), 1827-1828. Scopus1 |
| 2025 | Orsmond, A., Krishnan, G., Palmer, L. J., De Sousa, S. M. C., & McCormack, A. (2025). FGFR1 variation in the divergent settings of congenital hypopituitarism and pituitary tumours.. Pituitary, 28(2), 39. Scopus6 WoS5 Europe PMC3 |
| 2025 | De Sousa, S. M. C. (2025). From bench to bedside in the sella: translational developments in pituitary tumour genetics.. Endocrine-related cancer, 32(5), e240272. Scopus6 WoS6 Europe PMC2 |
| 2025 | Lim, W. T., Nenke, M., Rawlings, L., Wells, A., Vakulin, C., Waters, W., & De Sousa, S. (2025). A Mosaic PHEX Variant in Hypophosphatemic Rickets: Distinguishing Postzygotic Mutation from Sex Chromosome Aneuploidy. Calcified Tissue International, 116(1), 87. Scopus1 Europe PMC1 |
| 2025 | Orsmond, A., De Sousa, S. M. C., & McCormack, A. (2025). The landscape of germline variants in breast and colorectal cancer susceptibility genes in patients with pituitary tumours. Journal of Neuro Oncology, 175(1), 379-388. Scopus3 Europe PMC1 |
| 2025 | De Sousa, S. M., Davis, T. M., Harraway, J., Greenslade, M., Wu, K. H., Paul, R. G., . . . Greenfield, J. R. (2025). Australian and New Zealand joint society consensus statement on genetic testing for monogenic diabetes in adults.. The Medical journal of Australia, 223(9), 484-491. Scopus8 WoS7 Europe PMC6 |
| 2025 | Hilditch, C., Curtis, S., Cotton, S., LeBlanc, S., & De Sousa, S. (2025). Non-penetrant Xq26.3 duplication involving the invariant TAD border: clinical evidence for the VGLL1 region as the GPR101 pituitary enhancer of X-linked acrogigantism. Pituitary, 28(4), 5 pages. Scopus6 WoS6 Europe PMC4 |
| 2025 | Valetopoulou, A., Newall, N., Khan, D. Z., Borg, A., Bouloux, P. M. G., Bremner, F., . . . McLean, A. L. (2025). A core outcome set for pituitary surgery research: an international delphi consensus study. Pituitary, 28(4), 88. Scopus11 Europe PMC12 |
| 2025 | Ovenden, C. D., Candy, N., McNeil, J., Dolovac, R. B., Castle-Kirszbaum, M., Helal, A., . . . Psaltis, A. (2025). Systematic Review of Fluorescence Guided Surgery in Pituitary Neuroendocrine Tumours. Endocrine Oncology, 5(1), 10 pages. |
| 2025 | Ovenden, C., Mignone, E., Chapman, I., Torpy, D. J., Rankin, W., Jukes, A., . . . De Sousa, S. M. C. (2025). Early postoperative decline in insulin-like growth factor 1 (IGF-1) predicts surgical remission of acromegaly.. World neurosurgery, 205, 124611. Scopus1 WoS1 Europe PMC1 |
| 2025 | McNeil, J. M., Candy, N. C., Jukes, A. K., & De Sousa, S. M. C. (2025). Cabergoline monotherapy in GH- and PRL-cosecreting pituitary adenomas. Endocrine Oncology, 6(1), 5 pages. |
| 2024 | De Sousa, S. M. C., Jukes, A. K., Candy, N. G., Chapman, I. M., Torpy, D. J., Shivalingam, B., . . . Santoreneos, S. (2024). Tumour fibrosis in dopamine agonist-exposed prolactinomas is a diminishing concern.. Nat Rev Endocrinol, 20(5), 314. Scopus8 WoS8 Europe PMC6 |
| 2024 | De Sousa, S. M. C., McCormack, A., Orsmond, A., Shen, A., Yates, C. J., Clifton-Bligh, R., . . . Scott, H. S. (2024). Increased prevalence of germline pathogenic CHEK2 variants in individuals with pituitary adenomas.. J Clin Endocrinol Metab, 109(11), 2720-2728. Scopus13 WoS13 Europe PMC12 |
| 2024 | Mignone, E., Jukes, A. K., Valentine, R., Allison, R., & De Sousa, S. M. C. (2024). Aripiprazole use as a cause of dopamine agonist failure in the treatment of prolactinomas. Endocrine Oncology, 5(1), 8 pages. Scopus1 |
| 2023 | Hayes, A. G., Shirazi, M. G., Thiyagarajah, A., Torpy, D. J., & De Sousa, S. M. C. (2023). Cabergoline-associated valvulopathy of the tricuspid valve in the treatment of prolactinoma. Endocrine Oncology, 3(1), e220086. Europe PMC4 |
| 2023 | De Sousa, S. M. C., Lenders, N. F., Lamb, L. S., Inder, W. J., & McCormack, A. (2023). Pituitary tumours: molecular and genetic aspects. Journal of Endocrinology, 257(3), 16 pages. Scopus27 WoS24 Europe PMC20 |
| 2023 | De Sousa, S. M. C., Wu, K. H. C., Colclough, K., Rawlings, L., Dubowsky, A., Monnik, M., . . . Torpy, D. J. (2023). Identification of monogenic diabetes in an Australian cohort using the Exeter maturity-onset diabetes of the young (MODY) probability calculator and next-generation sequencing gene panel testing. Acta Diabetologica: an international journal devoted to the study of clinical and experimental diabetes and metabolism, 61(2), 181-188. Scopus6 WoS9 Europe PMC6 |
| 2023 | De Sousa, S. M. C., Shen, A., Yates, C. J., Clifton-Bligh, R., Santoreneos, S., King, J., . . . Scott, H. S. (2023). <i>PAM</i> variants in patients with thyrotrophinomas, cyclical Cushing's disease and prolactinomas. FRONTIERS IN ENDOCRINOLOGY, 14(1305606), 10 pages. WoS12 Europe PMC7 |
| 2022 | De Sousa, S. M. C., Carroll, R. W., Henderson, A., Burgess, J., & Clifton-Bligh, R. J. (2022). A contemporary clinical approach to genetic testing for heritable hyperparathyroidism syndromes. Endocrine, 75(1), 23-32. Scopus18 WoS18 Europe PMC18 |
| 2022 | Wu, D., Bampton, T. J., Scott, H. S., Brown, A., Kassahn, K., Drogemuller, C., . . . Coates, P. T. (2022). The clinical and genetic features of hereditary pancreatitis in South Australia.. Medical Journal of Australia, 216(11), 578-582. Scopus10 WoS8 Europe PMC8 |
| 2022 | De Sousa, S. M. C. (2022). Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management?. Endocrine Oncology, 2(1), R31-R50. Europe PMC29 |
| 2021 | Meyer, E. J., Spangenberg, L., Ramírez, M. J., De Sousa, S. M. C., Raggio, V., & Torpy, D. J. (2021). CBG Montevideo: A Clinically Novel SERPINA6 Mutation Leading to Haploinsufficiency of Corticosteroid-binding Globulin. Journal of the Endocrine Society, 5(9), 8 pages. Scopus10 WoS8 Europe PMC9 |
| 2021 | Miller, J. A., Gundara, J., Harper, S., Herath, M., Ramchand, S. K., Farrell, S., . . . Grossmann, M. (2021). Primary hyperparathyroidism in adults—(Part II) surgical management and postoperative follow-up: Position statement of the Endocrine Society of Australia, The Australian & New Zealand Endocrine Surgeons, and The Australian & New Zealand Bone and Mineral Society. Clinical Endocrinology, 101(5), 516-530. Scopus12 WoS11 Europe PMC11 |
| 2021 | Milat, F., Ramchand, S. K., Herath, M., Gundara, J., Harper, S., Farrell, S., . . . Grossmann, M. (2021). Primary hyperparathyroidism in adults—(Part I) assessment and medical management: Position statement of the endocrine society of Australia, the Australian & New Zealand endocrine surgeons, and the Australian & New Zealand bone and mineral society. Clinical Endocrinology, 100(1), 3-18. Scopus11 WoS11 Europe PMC12 |
| 2020 | De Sousa, S. M. C., Baranoff, J., Rushworth, R. L., Butler, J., Sorbello, J., Vorster, J., . . . Torpy, D. J. (2020). Impulse control disorders in dopamine agonist-treated hyperprolactinemia: prevalence and risk factors.. The Journal of clinical endocrinology and metabolism, 105(3), 108-118. Scopus78 WoS64 Europe PMC52 |
| 2020 | De Sousa, S. M. C., Manavis, J., Feng, J., Wang, P., Schreiber, A. W., Scott, H. S., & Torpy, D. J. (2020). A putative role for the aryl hydrocarbon receptor (AHR) gene in a patient with cyclical Cushing's disease. BMC Endocrine Disorders, 20(article no. 18), 2-6. Scopus9 WoS8 Europe PMC8 |
| 2020 | De Sousa, S. M. C., Toubia, J., Hardy, T. S. E., Feng, J., Wang, P., Schreiber, A. W., . . . Torpy, D. J. (2020). Aberrant Splicing of SDHC in Families With Unexplained Succinate Dehydrogenase-Deficient Paragangliomas. Journal of the Endocrine Society, 4(12), 1-12. Scopus15 WoS15 Europe PMC15 |
| 2019 | De Sousa, S. M. C., & Jesudason, D. (2019). Rebound vertebral and non-vertebral fractures during denosumab interruption in a postmenopausal woman. Clinical Endocrinology, 90(1), 250-252. Scopus5 WoS4 Europe PMC5 |
| 2019 | Du, Y. T., Moore, L., Poplawski, N. K., & De Sousa, S. M. C. (2019). Familial GATA6 mutation causing variably expressed diabetes mellitus and cardiac and renal abnormalities. Endocrinology, diabetes and metabolism case reports, 2019(1), 1-6. Scopus9 WoS2 Europe PMC6 |
| 2019 | De Sousa, S. M. C., Saleem, M., Rankin, W., & Torpy, D. J. (2019). Serum prolactin overestimation and risk of misdiagnosis. ENDOCRINOLOGY DIABETES & METABOLISM, 2(3), 4 pages. WoS6 Europe PMC5 |
| 2019 | De Sousa, S. M. C., Wang, P. P. S., Santoreneos, S., Shen, A., Yates, C. J., Babic, M., . . . Scott, H. S. (2019). The genomic landscape of sporadic prolactinomas. Endocrine pathology, 30(4), 318-328. Scopus23 WoS22 Europe PMC23 |
| 2019 | McCabe, M. J., Gauthier, M. E. A., Chan, C. L., Thompson, T. J., De Sousa, S. M. C., & Cowley, M. J. (2019). Development and validation of a targeted gene sequencing panel for application to disparate cancers. Scientific Reports, 9(1), 1-16. Scopus26 WoS24 Europe PMC26 |
| 2019 | De Sousa, S. M. C., & Jesudason, D. (2019). Cover Image, Volume 90, Issue 1. Clinical Endocrinology, 90(1). |
| 2018 | De Sousa, S., Sheriff, N., Tran, C., Menzies, A., Tsang, V., Long, G., & Tonks, K. (2018). Fall in thyroid stimulating hormone (TSH) may be an early marker of ipilimumab-induced hypophysitis. Pituitary, 21(3), 274-282. Scopus30 WoS26 Europe PMC25 |
| 2018 | De Sousa, S. M. C., Hardy, T. S. E., Scott, H. S., & Torpy, D. J. (2018). Genetic testing in endocrinology. Clinical Biochemist Reviews, 39(1), 17-28. Scopus20 Europe PMC12 |
| 2017 | De Sousa, S., Chapman, I., Falhammar, H., & Torpy, D. (2017). Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists. Endocrine, 55(2), 618-624. Scopus50 WoS43 Europe PMC39 |
| 2017 | De Sousa, S., McCabe, M., Wu, K., Roscioli, T., Gayevskiy, V., Brook, K., . . . McCormack, A. (2017). Germline variants in familial pituitary tumour syndrome genes are common in young patients and families with additional endocrine tumours. European Journal of Endocrinology, 176(5), 635-644. Scopus42 WoS35 Europe PMC33 |
| 2017 | De Sousa, S. M. C., McCormack, A. I., McGrath, S., & Torpy, D. J. (2017). Prolactin correction for adequacy of petrosal sinus cannulation may diminish diagnostic accuracy in Cushing's disease. Clinical Endocrinology, 87(5), 515-522. Scopus25 WoS24 Europe PMC17 |
| 2017 | De Sousa, S. M. C., Meyer, E. J., Rankin, W., Brautigan, P. J., Burt, M. G., & Torpy, D. J. (2017). Vasculogenic hyperprolactinemia: severe prolactin excess in association with internal carotid artery aneurysms. Pituitary, 20(6), 676-682. Scopus5 WoS4 Europe PMC4 |
| 2017 | De Sousa, S. M. C., Stowasser, M., Feng, J., Schreiber, A. W., Wang, P., Hahn, C. N., . . . Gagliardi, L. (2017). ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II). Journal of human hypertension, 31(12), 857-859. Scopus6 WoS3 Europe PMC5 |
| 2016 | de Sousa, S. M. C., & Mccormack, A. I. (2016). Cutaneous lichen amyloidosis in multiple endocrine neoplasia. Internal Medicine Journal, 46(1), 116-117. Scopus3 WoS2 Europe PMC3 |
| 2016 | De Sousa, S., & Norman, R. (2016). Metabolic syndrome, diet and exercise. Best Practice and Research: Clinical Obstetrics and Gynaecology, 37, 140-151. Scopus49 WoS40 Europe PMC39 |
| 2016 | De Sousa, S. M. C., Kassahn, K. S., McIntyre, L. C., Chong, C. E., Scott, H. S., & Torpy, D. J. (2016). Case report of whole genome sequencing in the XY female: identification of a novel SRY mutation and revision of a misdiagnosis of androgen insensitivity syndrome. BMC Endocrine Disorders, 16(1), 58-1-58-7. Scopus8 WoS4 Europe PMC4 |
| 2016 | De Sousa, S., Haghighi, K., Qiu, M., Greenfield, J., & Chen, D. (2016). Synchronous Nesidioblastosis, Endocrine Microadenoma, and Intraductal Papillary Mucinous Neoplasia in a Man Presenting with Hyperinsulinemic Hypoglycemia. Pancreas, 45(1), 154-159. Scopus11 WoS11 Europe PMC12 |
| 2016 | De Sousa, S. M. C., Maiti, K., Smith, R., & McCormack, A. I. (2016). Corticotrophin-releasing hormone (CRH) expression in the dermoid component of ovarian teratomas. Journal of the European Academy of Dermatology and Venereology, 30(5), 867-869. |
| 2015 | De Sousa, S. M. C., Earls, P., & McCormack, A. I. (2015). Pituitary hyperplasia: case series and literature review of an under-recognised and heterogeneous condition. ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2015, 7 pages. WoS21 Europe PMC25 |
| 2015 | Lam, T., Chan, M. M. K., Sweeting, A. N., De Sousa, S. M. C., Clements, A., Carlino, M. S., . . . Chipps, D. R. (2015). Ipilimumab-induced hypophysitis in melanoma patients: An Australian case series. Internal Medicine Journal, 45(10), 1066-1073. Scopus29 WoS26 Europe PMC23 |
| 2014 | De Sousa, S. M. C., Long, G. V., & Tonks, K. T. (2014). Ipilimumab-induced hypophysitis: Early Australian experience. Medical Journal of Australia, 201(4), 198-199. Scopus8 WoS8 Europe PMC7 |
| Year | Citation |
|---|---|
| 2018 | Hardy, T. S. E., De Sousa, S. M. C., & Norman, R. J. (2018). Obesity and reproduction. In M. J. Skinner (Ed.), Encyclopedia of Reproduction (2 ed., pp. 87-93). US: Academic Press. DOI Scopus1 |
| 2018 | Hardy, T. S. E., De Sousa, S. M. C., & Norman, R. J. (2018). Obesity and Reproduction. In Encyclopedia of Reproduction Volume 1 6 Second Edition (Vol. 4, pp. 87-93). DOI |
| 2015 | De Sousa, S., & Norman, R. J. (2015). A patient found to have Cushing syndrome. In N. S. Macklon, H. M. Fatemi, R. J. Norman, & P. Patrizio (Eds.), Case Studies in Assisted Reproduction: Common and Uncommon Presentations (pp. 50-52). Cambridge: Cambridge University Press. DOI |
| 2013 | Hardy, T., De Sousa, S., & Norman, R. J. (2013). Polycystic ovary syndrome: Prognosis and risk of comorbidity. In Novel Insights into the Pathophysiology and Treatment of Pcos (pp. 123-137). Future Medicine Ltd. DOI Scopus2 |
| Year | Citation |
|---|---|
| 2024 | Wu, D., Zuiani, J. D., Drogemuller, C. J., De Sousa, S. M. C., Adelson, D., Torpy, D., & Coates, P. T. (2024). The epidemiology of hereditary pancreatitis in Australia and its effect on patient of total pancreatectomy with islet auto-transplantation (TPIAT). In Abstracts of the 30th International Congress of The Transplantation-Society (TTS2024), as published in Transplantation Vol. 108 (pp. 382). Istanbul, TURKEY: Lippincott Williams & Wilkins. DOI |
| 2018 | De Sousa, S. M. C., McCormack, A. I., McGrath, S., & Torpy, D. J. (2018). Use of prolactin in inferior petrosal sinus sampling is misleading. In CLINICAL ENDOCRINOLOGY Vol. 89 (pp. 32). Perth, AUSTRALIA: WILEY. WoS1 |
| Year | Citation |
|---|---|
| 2017 | De Sousa, S. M. C., Chapman, I. M., Falhammar, H., & Torpy, D. J. (2017). Dopa-testotoxicosis: a novel drug toxicity of dopamine agonists in male prolactinoma patients. Poster session presented at the meeting of CLINICAL ENDOCRINOLOGY. WILEY-BLACKWELL. |
| 2017 | de Sousa, S. M. C., Stowasser, M., Feng, J., Schreiber, A. W., Hahn, C. N., Torpy, D. J., . . . Scott, H. S. (2017). Sequence variants in ARMC5 are not implicated in familial hyperaldosteronism type II. Poster session presented at the meeting of Clinical endocrinology. UK: Wiley-Blackwell Publishing. |
| 2017 | Meyer, E. J., De Sousa, S. M. C., Burt, M. G., & Torpy, D. J. (2017). Cavernous internal carotid artery ansurysm: a rare cause of marked hyperprolactinaemia. Poster session presented at the meeting of CLINICAL ENDOCRINOLOGY. WILEY-BLACKWELL. |
- RACP Advanced Training Supervisor 2026 –
- Central Adelaide Local Health Network/Adelaide University Clinician PhD Pathway Development & Mentor Panel 2023 –
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2026 | Principal Supervisor | Development of Machine Learning Models to Optimise Assessment and Management of Functioning Pituitary Tumours | Doctor of Philosophy | Doctorate | Full Time | Dr Edward Mignone |
| 2025 | Co-Supervisor | Improving safety and efficacy in endoscopic pituitary adenoma surgery | Doctor of Philosophy | Doctorate | Full Time | Mr Christopher Dillon Ovenden |
| 2025 | Principal Supervisor | Novel applications of molecular imaging and theranostics in endocrine neoplasia. | Doctor of Philosophy | Doctorate | Part Time | Dr James McNeil |
| 2022 | Co-Supervisor | The Genetic Epidemiology of Hereditary Pancreatitis in Australia and its effects on patients of Total Pancreatectomy with Auto Islet Transplantation. | Doctor of Philosophy | Doctorate | Full Time | Mr Denghao Wu |
| Date | Role | Research Topic | Location | Program | Supervision Type | Student Load | Student Name |
|---|---|---|---|---|---|---|---|
| 2025 - ongoing | External Supervisor | Novel circulating biomarkers of neuroendocrine tumours | University of Melbourne | - | Doctorate | - | Angie Xiang |
| 2025 - ongoing | External Supervisor | Characterising rare endocrine genetic neoplasia | University of Queensland | - | Master | - | Raquel Maggacis |
| Date | Role | Board name | Institution name | Country |
|---|---|---|---|---|
| 2025 - ongoing | Member | CALHN Clinical Council | Central Adelaide Local Health Network | Australia |
| 2024 - 2026 | Secretary | ESA Council | Endocrine Society of Australia | Australia |
| 2022 - 2026 | Board Member | ESA Council | Endocrine Society of Australia | Australia |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2025 - 2026 | Chair | Pituitary Genetics (PitGen) Consensus Group | Pituitary Society | United States |
| 2024 - ongoing | Chair | South Australian Pituitary Research Group | Royal Adelaide Hospital | Australia |
| 2023 - ongoing | Member | Endocrine Tumor Predisposition Syndrome Variant Curation Expert Panel | ClinGen | United States |
| 2023 - 2025 | Co-Chair | ANZ Monogenic Diabetes Guidelines Working Group | Endocrine Society of Australia | Australia |
| 2023 - ongoing | Member | Central Adelaide Local Health Network/Adelaide University Clinician PhD Pathway Development & Mentor Panel | Adelaide University | Australia |
| 2023 - ongoing | Member | ANZ Hyponatraemia Guidelines Working Group | Endocrine Society of Australia | Australia |
| 2022 - 2024 | Member | ANZ Hyperparathyroidism Guidelines Working Group | Endocrine Society of Australia | Australia |
| 2021 - ongoing | Member | Cancer Genetics Reference Committee | eviQ | Australia |
| 2020 - ongoing | Chair | EndoGen Steering Committee | EndoGen National Endocrine Genetics Network | Australia |
| 2019 - 2022 | Co-Chair | ESA Early Career Researcher Committee | Endocrine Society of Australia | Australia |
| 2018 - 2018 | Chair | ESA Annual Scientic Meeting Local Organising Committee | Endocrine Society of Australia | Australia |
| 2015 - 2016 | Member | RACP Specialist Advisory Committee (Endocrinology) | Royal Australasian College of Physicians | Australia |
| Date | Role | Editorial Board Name | Institution | Country |
|---|---|---|---|---|
| 2025 - ongoing | Associate Editor | Endocrine Oncology | Bioscientifica | United Kingdom |
| 2025 - ongoing | Consulting Editor | Endocrine-Related Cancer | Bioscientifica | United Kingdom |
Connect With Me
External Profiles
